Case Report: Subconjunctival Bevacizumab for the Treatment of Refractory Pseudophakic Cystoid Macular Edema
CONCLUSIONS
The repeated subconjunctival injections of bevacizumab were effective and well tolerated in pseudophakic cystoid macular edema. Subconjunctival bevacizumab may be a safe alternative to intravitreal applications in patients with pseudophakic cystoid macular edema.
Source: Optometry and Vision Science - Category: Opthalmology Tags: REPORTS Source Type: research
More News: Avastin | Cataract Removal | Cataracts | Corticosteroid Therapy | Opthalmology | Science | Triamcinolone | Vitamin A